enVVeno Medical Corp

NVNO Nasdaq SEC CIK 1661053
Follow enVVeno Medical Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$4.4M +3.8% vs same quarter last year
EPS, diluted −$6.29 +20.3% vs same quarter last year
Operating cash flow −$3.2M +27.6% vs same quarter last year
Operating income −$4.5M +7.1% vs same quarter last year
Net income by quarter
−$6.2M
−$4.5M
−$6.7M
−$4.5M
−$3.7M
−$3.8M
−$3.6M
−$4.4M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income10 fiscal years
  • Revenue
  • Net income
−$30M−$20M−$10M$0$10MFY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25-−$19.5M
FY24-−$21.8M
FY23-−$23.5M
FY22-−$24.7M
FY21-−$16.5M
FY20-−$9.1M
FY19$31.2K−$7.6M
FY18$186.6K−$13M
FY17$422.1K−$7.8M
FY16--
MarginsShare of revenue
  • Operating margin
  • Net margin
−30000%−20000%−10000%0%FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25--
FY24--
FY23--
FY22--
FY21--
FY20--
FY19−24566.5%−24406.7%
FY18−4210.5%−6991.5%
FY17−1445.9%−1845.8%
FY16--
Free cash flowOperating cash flow minus capital expenditure
−$20M−$15M−$10M−$5M$0FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$15.6M
FY24−$16.9M
FY23−$18.9M
FY22−$15.7M
FY21−$12.2M
FY20−$7.9M
FY19−$6.3M
FY18−$6.4M
FY17−$4.2M
FY16-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • enVVeno Medical
  • Healthcare median
−30000%−20000%−10000%0%FY17FY19FY21FY23FY25
Show the numbers
YearenVVeno MedicalHealthcare median
FY25-−30.6%
FY24-−47%
FY23-−58%
FY22-−80.4%
FY21-−71.8%
FY20-−62.2%
FY19−24406.7%−46.2%
FY18−6991.5%−49.6%
FY17−1845.8%−45.9%
FY16-−36%